ArticleBMC pulmonary medicine2023

Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: a real-world observation study.

Ke Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.